Figure 23. Effects of FDA-approved pharmacological ADHD treatment on behavior (SMD) The figure is a forest plot that displays all studies that reported on the effects of FDA-approved pharmacological ADHD treatment on behavior using the standardized mean difference (SMD). The figure also shows the pooled result across studies.

Figure 23Effects of FDA-approved pharmacologic ADHD treatment on behavior (SMD)

Notes: ADHD = attention deficit hyperactivity disorder, FDA = Food and Drug Administration, NS-NRI-ATX atomoxetine, NS-ALA-CLON clonidine, RE = random effects, S-MPH-IR immediate release methylphenidate, SMD = Standardized Mean Difference

From: 5, Results: Treatment of ADHD

Cover of ADHD Diagnosis and Treatment in Children and Adolescents
ADHD Diagnosis and Treatment in Children and Adolescents [Internet].
Comparative Effectiveness Review, No. 267.
Peterson BS, Trampush J, Maglione M, et al.
Copyright Notice

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.